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Involvement of the central nervous system (CNS) is not considered a typical manifestation of dengue, but reports indicate it may occur in as many as 4% of cases. It could be conjectured that the incidence might be higher in fatal cases of dengue, and this possibility has now been addressed.

During a dengue epidemic in the northeastern Brazilian State of Ceará, which is endemic for dengue types 1--3, Araújo and colleagues determined the incidence of CNS involvement by the virus at postmortem examination in subjects who died of a suspected infectious disease. Evidence of systemic dengue virus infection was detected in 84 of 150 subjects (56%), and 41 of the 84 (48.8%) had ≥1 cerebrospinal fluid (CSF) studies indicative of CNS infection by this flavivirus. These CSF studies included virus isolation in 1, detection of RNA by reverse-transcription polymerase chain reaction in 7, immunoglobulin M antibody to dengue in 27, and detection of nonstructural 1 antigen in 22. Of the 41 with evidence of CNS involvement, 8 (19.5%) had had clinical evidence of meningitis, 14 (34.1%) had meningoencephalitis, and 19 (46.3%) had encephalitis.

Knowledge that dengue virus may invade the CNS also leads to the question of the role it plays in patients presenting with symptoms or signs of CNS infection. In a separate study, Araújo and colleagues addressed this issue by retrospectively examining the incidence of dengue infection in patients with suspected viral meningitis or meningoencephalitis in the same endemic region of Brazil, possibly during a period of epidemic activity. They studied CSF from 183 living patients and 26 deceased subjects. Using the same diagnostic tests as in their other study, they found evidence of CNS involvement by dengue virus in 8 (3.6%) individuals, 5 of the 183 living patients and 3 of the 26 deceased subjects.

Thus, at least in Brazil, dengue virus is an infrequent etiology in patients with suspected meningitis or meningoencephalitis, In patients dying of infection due to this virus, however, approximately half have evidence of CNS invasion.
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The recommended duration of therapy of latent tuberculosis with daily rifampin alone is 4 months; with weekly observed isoniazid (INH) and rifapentine it is 3 months, while that of daily INH alone is 6-9 months. The requirememt for the prolonged duration of INH administration when administered as a single agent is believed to be the result of its inactivity against nonreplicating bacilli. In addition, INH is not active under hypoxic conditions, as exist in caseating granulomas. Metronidazole, on the other hand, though not active in an aerobic environment, is bactericidally active in vitro against nonreplicating *Mycobacterium tuberculosis* under hypoxic conditions in vitro.

Lin and colleagues examined the efficacy of metronidazole administration in a cynomolgous monkey model of latent tuberculosis in which the infection could be activated by administration of anti--tumor necrosis factor antibody. In this model, administration of INH alone for 6 months or INH plus rifampin for 2 months were each highly effective in the prevention of reactivation disease, while administration of metronidazole alone for 2 months was equally effective. Metronidazole also demonstrated benefit in active tuberculosis when added to INH and rifampin with all 3 administered for only 3 months.

The potential role of metronidazole in the treatment of multidrug-resistant tuberculosis is currently being examined in a trial in South Korea, in which patients are randomized to receive it or placebo in addition to a standard second-line regimen \[[@CIS913C1-1]\].
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The standard approach to the neutropenic patient who presents with fever is the performance of a careful clinical and microbiological evaluation and the immediate initiation of empiric broad-spectrum antibiotic therapy. The presence of an infection is, however, documented in only approximately 40%--60%. The role of viruses is less well defined. Excluding allogeneic hematopoietic stem cell recipients, Öhrmalm and colleagues in Stockholm prospectively studied 123 adults with fever and neutropenia as well as 36 neutropenic patients who were afebrile. Nasopharyngeal (NP) aspirates were examined with polymerase chain reaction testing for the presence of a broad range of common respiratory viruses, and blood was screened for viruses commonly identified at that site in immunocompromised patients.

A viral pathogen was detected in 35% of subjects, with 18% of NP aspirates and 22% of blood samples positive. Fever and a diagnosis of chronic lymphocytic leukemia were significantly overrepresented among those with detectable virus. Only 58% of those with a virus detected in NP aspirates had upper respiratory symptoms while such symptoms were present in 17% with negative NP samples. A viral pathogen was detected in NP aspirates in 25 febrile patients (23%) and only 1 afebrile patient (3%) with a rhinovirus infection. The respiratory viruses detected in the 25 with fever included rhinovirus (n = 10), respiratory syncytial virus (n = 5), adenovirus (n = 6), influenza (n = 3), and metapneumovirus (n = 2).

Of the 35 patients with positive blood samples, BK virus was detected in 18, cytomegalovirus in 8, parvovirus B19 in 6, Epstein-Barr virus in 6, and adenovirus in 1, with \>1 virus detected in a number of individuals. In most instances, the viral load was \<1000 copies/mL except in the following patients, all of whom had fever: 1 patient with cytomegalovirus (1800 copies/mL), 4 with BK virus (3500, 4800, 7000, and 38 000 copies/mL), and 1 with parvovirus B19 (9500 copies/mL).

Among the patients with febrile neutropenia, 41 (33%) had a documented bacterial infection and a concomitant viral infection was found in 15 (37%) of these. Viewed from the opposite direction, at least 1 viral pathogen was detected in 42% of patients with febrile neutropenia, with 29% of the total also having a documented bacterial infection.

A separate recent study of 50 children with febrile neutropenia using Luminex xTAG multiplex reverse-transcription polymerase chain reaction to amplify nucleic acid in respiratory secretions found that 52% had evidence of viral respiratory infection \[[@CIS913C1-2]\]. The most frequently detected was rhinovirus/enterovirus, followed by small numbers of influenza, parainfluenza, coronavirus, and metapneumovirus. Neither adenovirus or RSV were detected. Respiratory symptoms were present in 25 episodes of febrile neutropenia, 18 (72%) of whom were virus positive, while only 8 (32%; *P* = .008) of 29 without fever were associated with viral nucleic acid detection.

This analysis provides evidence of the presence of known common pathogenic viruses in patients with febrile neutropenia, a subject that requires further exploration. The application of sensitive methods that do not require use of virus-specific primers, such as various new generation deep sequencing techniques, may soon provide some real surprises.
